Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02728999
Other study ID # AHCIRB 5589 Trendelenburg
Secondary ID
Status Terminated
Phase N/A
First received March 1, 2016
Last updated January 18, 2018
Start date June 2013
Est. completion date July 20, 2016

Study information

Verified date January 2018
Source Advocate Health Care
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patient/Population: Women over the age of 18, who are not pregnant and are undergoing benign, robotic-assisted gynecologic procedures at Lutheran General Hospital.

Intervention: Decreasing the angle of Trendelenburg for the procedure Control: Steep Trendelenburg, which is the usual standard of care, to the limit of the operative bed, which is 30 degrees.

Outcome: Outcomes will include the mean angle of Trendelenburg in the experimental arm and the difference in Trendelenburg between the two arms. Additional outcomes included will be end tidal Carbon dioxide, peak airway pressure, mean arterial pressure, heart rate and arterial Carbon dioxide. Secondary outcomes will include operative time, blood loss and conversion to laparotomy.


Description:

For any patient undergoing robotic-assisted benign laparoscopic procedures at Lutheran General Hospital were eligible to participate. Each subject was randomized to steep or a decreased angle of Trendelenburg. While under anesthesia an arterial line would be placed to monitor vital signs. At specific time points throughout surgery, all vital signs were measured including End Tidal CO2, peak airway pressure, mean arterial pressure, heart rate and arterial CO2 as well as operative time, blood loss and conversion to laparotomy.

The arterial line was removed at the conclusion of the case, and all variables will be compared between the two cohorts.


Recruitment information / eligibility

Status Terminated
Enrollment 22
Est. completion date July 20, 2016
Est. primary completion date July 20, 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- all women at Lutheran General Hospital undergoing robotic-assisted benign gynecologic procedures and who agree to participate in the study.

- Women who are 18 years or older on the day of surgery.

- Patients with any co-morbidity or prior surgery, as long as they are cleared by their surgeon and anesthesia to undergo robotic-assisted surgery.

Exclusion Criteria:

- pregnant women

- Anyone who is less than 18 years old on the day of surgery.

- Anyone who does not have the capacity to make independent medical decisions.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Steep Trendelenburg
•Subjects who undergo steep Trendelenburg will remain in 30 degrees of Trendelenburg, and the da Vinci robot will be docked. After subjects are asleep an arterial line will be place in one wrist by the anesthesiologist. It will be removed at the conclusion of the procedure.
Decreased Trendelenburg
•Subjects who undergo decreased Trendelenburg will be taken out of Trendelenburg to the minimal angle possible that enables adequate visualization, as determined by the primary surgeon, at which time robot will be docked. After subjects are asleep an arterial line will be place in one wrist by the anesthesiologist. It will be removed at the conclusion of the procedure.

Locations

Country Name City State
United States Advocate Lutheran General Hospital Park Ridge Illinois

Sponsors (1)

Lead Sponsor Collaborator
Advocate Health Care

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary • Mean Angle of Trendelenburg during surgery (Degrees of the operative head down, measured by electronic angle meter) and the difference in the two arms Measured using electronic Angle Meter from supine to Trendelenburg in degrees (0-30) 0-240 minutes
Secondary Cardiovascular Outcomes- Heart rate Heart rate (beats per minute) measured in beats per minute by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and at the end of the case. 0-240 minutes
Secondary Respiratory Parameter- arterial CO2 Arterial CO2- Measured by taking an arterial blood gas from the arterial line by the anesthesiologist at the beginning of the case prior to insufflation, and then every hour while in Trendelenburg. 0-240 minutes
Secondary Respiratory Outcomes- End Tidal CO2 End Tidal CO2 measured in mmHg by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and then at the end of the case. 0-240 minutes
Secondary Respiratory Outcomes- Peak Airway Pressure Peak Airway Pressure (mm Hg) measured in mmHg by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and then at the end of the case. 0-240 minutes
Secondary Cardiovascular Outcomes- Mean arterial Pressure Mean arterial pressure (mm hg) measured in mmHg by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and then at the end of the case. 0-240 minutes
Secondary Operative Time The operative time will be measured (minutes) from the time the robot was docked until it is undocked. 1-240 minutes
Secondary Estimated Blood Loss The blood loss (mL) will be measured by subtracting the irrigation fluid used from the fluid suctioned out during the procedure. 0-240 minutes
Secondary Redocking of the robot It will be recorded whether the robot required undocking, placement in greater Trendelenburg and redocking of the robot in order to complete the procedure. 0-240 minutes
Secondary Conversion of surgical approach It will be recorded whether the surgical approach was transitioned to traditional laparoscopy or laparotomy versus a robotic-assisted procedure as scheduled. 0-240 minutes
See also
  Status Clinical Trial Phase
Completed NCT01566669 - Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery N/A